Preclinical safety evaluation of calcineurin inhibitors delivered through an intraductal route to prevent post-ERCP pancreatitis demonstrates endocrine and systemic safety

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2023
Source ID
10.1016/j.pan.2023.03.009

Entities

People

  • Asna Khalid
  • Cheng-yu Tsai
  • Gayathri Swaminathan
  • Georgios I Papachristou
  • Jianbo Ni
  • Jing Wang
  • Judy‐April Murayi
  • Li Wen
  • Mang Yu
  • Monique T. Barakat
  • Pasha Reza Shams Azar
  • Rita Bottino
  • Ronald Poropatich
  • Sohail Z Husain
  • Thottala Jayaraman
  • Ying Ding
  • Yu-chu Lin

Organizations

  • National Institutes of Health
  • United States Department of Defense